Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Novartis, Astellas Pharma, Novartis Pharma
OpenAlex ID: W2108565052
